Could less steroids be just as good for kids with kidney disease?

NCT ID NCT06635720

First seen May 13, 2026 · Last updated May 13, 2026

Summary

This study tests whether a lower dose of the steroid prednisone can safely treat relapses of nephrotic syndrome in children, compared to the standard dose. About 50 children aged 1-18 with active relapses will take part. The goal is to see if a reduced-dose approach is feasible and safe, potentially reducing side effects from long-term steroid use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEPHROTIC SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • The Hospital for Sick Children

    Toronto, Ontario, M5G 1E8, Canada

Conditions

Explore the condition pages connected to this study.